One-year access to more than 500 world journals available in the system
-
http://medilib.ir
- Duration of Time : 365 Day
Price : 300$- Special Price : 100$
Journals package 1months
-
http://medilib.ir
- Duration of Time : 31 Day
Price : 100$- Special Price : 50$
Future of once-weekly insulins in type 2 diabetes: efficacy and safety
A community-based landmark trial to save the lives of pregnant adolescents and their newborns in sub-Saharan Africa
Clozapine: old drugs require efforts to improve patient experience and access
Reorienting frailty in clinical practice, public health, and policy: the Lancet Commission on Frailty
US Supreme Court upholds Tennessee law denying adolescents gender-affirming care
Genocide in Gaza: moral and ethical failures of medical institutions
Leptospirosis deaths in children in the Amazon: syndemic inequities
Population health impact of NICE-recommended new drugs – Authors' reply
Once-weekly insulin efsitora alfa versus once-daily insulin degludec in adults with type 2 diabetes currently treated with basal insulin (QWINT-3): a phase 3, randomised, non-inferiority trial
Once-weekly insulin efsitora alfa versus once-daily insulin glargine U100 in adults with type 2 diabetes treated with basal and prandial insulin (QWINT-4): a phase 3, randomised, non-inferiority trial
Community-based mentoring to reduce maternal and perinatal mortality in adolescent pregnancies in Sierra Leone (2YoungLives): a pilot cluster-randomised controlled trial
Understanding the drivers and consequences of early-onset type 2 diabetes
Managing early-onset type 2 diabetes in the individual and at the population level
